Back to search

National and Kapodistrian University of Athens

Mελέτη της ενεργοποίησης του κυτταρικού μονοπατιού PI3K/Akt στο λέμφωμα μανδύα

Abstract

dc:description

Aberrant activation of phosphoinositide-3 kinase/Akt (PI3K/Akt) and mammalian target of rapamycin (mTOR) signaling are implicated in the pathogenesis of mantle cell lymphoma (MCL). In this study, 35 tissue samples from primary MCL cases and 2 MCL cell lines (Granta-519 and Rec-1) were used to investigate the PI3K/Akt signaling pathway. The aims of the study were: a) Το study the activation of kinase Akt (Ser473pAkt) using Western blot and immunohistochemistry, b) Το investigate the Western blot and immunohistochemical expresstion levels of phosphatase PTEN, which is a known inhibitor of PI3K/Akt signaling pathway, c) To determine gene copy number of PIK3CA, which encodes for the p110α catalytic subunit of PI3K, using quantitative real-time PCR (qRT-PCR) and fluorescence in situ hybridization (FISH), d) To measure PIK3CA transcription levels using quantitative real-time reverse transcription-PCR, e) To investigate somatic mutations of PIK3CA within exons 9 and 20 using PCR-Sequencing, f) To investigate the immunohistochemical expression of Ser2448pmTOR [indicative of mTOR complex 1 (mTORC1) activation status], g) To investigate the immunohistochemical expression of hypoxia-inducible factor 1 alpha (HIF-1α), hypoxia-inducible factor 2 alpha (HIF-2α), as well as of the cell cycle regulators p53, p21 and p27, h) To investigate apoptosis using the Tunel assay and immunohistochemistry. More specifically, the Tunel method was used to check for apoptotic cells and additionally immunohistochemistry was applied to investigate the expression of the proteins caspase 3 and survivin, which are both related to apoptosis. Finally, flow cytometry was used to assess apoptosis after treatment of Granta-519 and Rec-1cell lines with LY294002, an inhibitor of PI3K.Thirty six percent of MCL cases and also the 2 MCL lines had Ser473pAkt expression. PTEN protein expression was present in all 14 MCL cases and the 2 MCL cell lines that were analyzed by Western blotting. Five of 33 (15%) cases tested by immunohistochemistry had loss of PTEN expression. Fifteen of 22 (68%) MCL cases and the 2 MCL cell lines harbored a gain (≥3) of PIK3CA gene copy number. In addition, cases with increased PIK3CA gene copy number had elevated PIK3CA mRNA levels. Somatic mutations of PIK3CA gene were not detected. Τhe status of Akt phosphorylation correlated with PIK3CA gene amplification in 7 of 12 (58%) MCL cases and with the loss of PTEN expression in 5 of 12 (42%) MCL cases. Ιmmunohistochemical expression of Ser2448pmTOR, HIF-1α, HIF-2α, p53, p21 and p27 was detected in 61,7%, 73,5%, 23,5%, 18,2%, 0% and 100% of cases respectively. Seventy two percent of patients who expressed HIF-1α had also Ser2448pmTOR expression (p=0.041). In addition, HIF-1α expression correlated to an elevated (≥30%) Ki-67 (p=0.031) and high HIF-1α expression correlated to blastoid variant of disease (p=0.017). Apoptotic cells were rarely found (<1% of the lymphoma cells) in the MCL cases that were analyzed by the Tunel assay. Ιmmunohistochemical expression of caspase 3 and survivin was detected in all cases (100%) that were examined. Finally, inhibition of PI3K by treatment of MCL lines with LY294002 induced increased apoptosis after 24h and 48h.In conclusion, this study describes the following innovations: a) Amplification of the PIK3CA gene is a frequent genetic alteration in MCL. This finding comprises the first report of gain of PIK3CA copy number in hematologic malignancies, b) PIK3CA gene amplification contributes to the oncogenic activation of the PI3K/Akt signalling pathway in MCL. In addition, PIK3CA gene amplification and PTEN protein expression loss are almost mutually exclusive mechanisms of Akt activation in MCL. These data raise the possibility that PIK3CA can be used as a molecular target in MCL, c) There is a common expression of HIF-alphas, especially HIF-1α in MCL patients , d) An overall activation of mTORC1→HIF-1α axis in MCL is suggested, which possibly contributes to the pathogenesis of the disease. Furthermore, a potential role of Ser2448pmTOR in the regulation of HIF-1α is implied. This is the first report which describes an activated mTORC1→HIF-1α axis in lymphomas, e) HIF-1α expression in MCL patients correlates to the adverse prognostic markers blastoid variant and elevated ( ≥30%) Ki-67 and therefore appears to be associated with more aggressive disease. Τhe approach that was followed in this research led to a thorough study of PI3K/Akt signalling pathway in MCL and contributed to the comprehension of the pathophysiology, which is necessary in order to achieve more efficient control of the disease in the future.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2012

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Argyriou, Pinelopi
  • Αργυρίου, Πηνελόπη

Subjects

dc:subject × 19

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/29455

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Argyriou, Pinelopi; Αργυρίου, Πηνελόπη. Mελέτη της ενεργοποίησης του κυτταρικού μονοπατιού PI3K/Akt στο λέμφωμα μανδύα. National and Kapodistrian University of Athens, 2012. http://hdl.handle.net/10442/hedi/29455